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Abstract
Background: Determinants of public healthcare expenditures in type 2 diabetics are not well investigated in
developing nations and, therefore, it is not clear if higher physical activity decreases healthcare costs. The purpose
of this study was to analyze the relationship between physical activity and the expenditures in public healthcare
on type 2 diabetes mellitus treatment.
Methods: Cross-sectional study carried out in Brazil. A total of 121 type 2 diabetics attended to in two Basic
Healthcare Units were evaluated. Public healthcare expenditures in the last year were estimated using a specific
standard table. Also evaluated were: socio-demographic variables; chronological age; exogenous insulin use;
smoking habits; fasting glucose test; diabetic neuropathy and anthropometric measures. Habitual physical activity
was assessed by questionnaire.
Results: Age (r = 0.20; p = 0.023), body mass index (r = 0.33; p = 0.001) and waist-to-hip ratio (r = 0.20; p = 0.025)
were positively related to expenditures on medication for the treatment of diseases other than diabetes. Insulin use
was associated with increased expenditures. Higher physical activity was associated with lower expenditure,
provided medication for treatment of diseases other than diabetes (OR = 0.19; p = 0.007) and medical
consultations (OR = 0.26; p = 0.029).
Conclusions: Type 2 diabetics with higher enrollment in physical activity presented consistently lower healthcare
expenditures for the public healthcare system.
Keywords: Diabetes Mellitus expenditures, physical activity
Background
During the last decades, the prevalence of some chronic
diseases increased significantly in the worldwide popula-
tion [1-3]. The burden associated with the outcomes of
such diseases generates a substantial impact in public
health costs. In particular, Type 2 Diabetes Mellitus
(T2DM) may be considered one of the main chronic
diseases related to increased healthcare costs, due to the
set of co-morbidities derived from its onset.
The economic costs from T2DM complications were
estimated to be higher than US$130 billion in the Uni-
ted States during 2002 [4], a situation similar to
developing countries. In Latin America, costs due to dia-
betes were estimated to be US$65 billion during 2000
[5]. Specifically in Brazil, T2DM represents a significant
public health cost in hospitalizations [6], especially con-
sidering the accelerated process of demographic
transition.
Habitual physical activity presents a protective effect
against the onset of some diseases, such as overweight
and T2DM [7-10]. Diloreto et al. [11] in a longitudinal
design carried out with Italian T2DM subjects, identified
that increased physical activities during leisure time may
result in cost savings in healthcare. Beltoldi et al. [12]
also observed a significant negative association between
physical activity and the need to use medication.
Despite these results there is still a lack of studies on
the association between habitual physical activity and
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nations, therefore, there is no evidence that the promo-
tion of physical activity by government could be useful
to reduce T2DM treatment costs. Thus, the purpose of
this study was to analyze the relation between the level
of physical activity and the expenditures in public
healthcare with T2DM treatment.
Methods
Sample
Ac r o s s - s e c t i o n a ls t u d yw i t hr e t r o s p e c t i v ed e s i g nw a s
carried out in the city of Bauru, a large city in the state
of São Paulo, Brazil, with approximately 345,000 inhabi-
tants [13]. The study was approved by the Ethics Com-
mittee Group from the Universidade Estadual Paulista -
UNESP (Rio Claro campus) and all subjects were
informed of the aim of the study and their rights not to
participate or to abandon the study at any time without
constraints. All subjects were asked to sign a standard
written consent form (Process number 6898-2008). The
sample size was estimated based on the prevalence of
physical inactivity among diabetic subjects (47%), using
as parameters a 10% error, 80% power and 5% signifi-
cance, considering an estimated 33,700 diabetic indivi-
duals in the population (9.7% prevalence of T2DM in
the state of São Paulo). A sample size of 118 diabetic
individuals was estimated to be representative and a
10% expected sample loss was included, resulting in the
enrollment of 130 T2DM individuals to be included in
the study.
In the Brazilian public health system, each Basic
Healthcare Unit (BHU) serves the population of a parti-
cular region of the city and this is where a variety of
health professionals are available (e.g. dentist, general
practitioner, gynecologist, obstetrician, pediatrician and
psychiatrist) and health services, such as vaccines, medi-
cation dispensing and monitoring of patients with arter-
ial hypertension and T2DM are administered [14].
Services are free and focused exclusively on prevention.
Emergencies, surgical procedures and complex exams
are referred directly to hospitals [14]. BHU services are
funded by the State and Municipal Health Secretary.
The Municipal Health Secretary granted access to the
patients’ medical records of two BHU (the city has 17).
Potential patients were identified through analysis of the
medical records, in which three inclusion criteria were
adopted: (i) individuals should have been previously
diagnosed with T2DM; (ii) age ≤ 75 years-old, in order
to avoid age-related interference in diabetic neuropathy
diagnosis [15]; and (iii) individuals would have to pre-
sent at least one-year complete medical records previous
to the interview.
All patients registered at a BHU and who met the
inclusion criteria were contacted by phone (n = 186),
and 130 were found and agreed to participate. Among
the 130 diabetics contacted, nine were excluded due to
incomplete data (e.g. fail in body composition assess-
ment and age higher than 75 years) and consequently
only 121 individuals were included in the study. Inter-
views were performed from January to February, 2009.
Interviews and all anthropometric measurements were
performed by trained researchers.
Public healthcare expenditures
The period of time considered to assess expenditures for
T2DM treatment in public healthcare facilities was one
year prior to the interview conducted in the study.
Expenditures due to T2DM treatment were estimated
including all items registered in the medical records
from each T2DM patient in the BHUs. The following
data was gathered: laboratory tests performed (per-
formed in private laboratories that were paid by BHU);
medical consultations (e.g. dentists, gynecologist, obste-
trician, general practitioner and psychiatrist); medication
dispensed (separating medication designed for T2DM
treatment [e.g. metamorfin, insulin and oral antidiabetic
agents] and medication for other diseases [e.g. antihy-
pertensive medicines and hypolipidemic agents]). Hospi-
talizations and emergency room visits are not services
related to BHU and, therefore, were not added to our
expenditures.
A specific standard table, including public healthcare
reimbursement values, were provided by BHU offices
and used in order to compute monetary values of
laboratory tests and medical specialist consultations
[ 1 4 ] .I n v o i c e so b t a i n e df r o mB H U sw e r eu s e dt oc o m -
pute the dosage and the market prices of medication
used by T2DM patients. All expenditures were com-
puted in the Brazilian currency (Real) and converted to
US dollar using the average value of the dollar against
the Brazilian currency in the 12 months of 2008 (US$
1.83).
Seven categories of healthcare expenditures were cre-
ated: (i) laboratory tests; (ii) medication ([iii] medication
for T2DM treatment and [iv] medication for treatment
of other diseases); (v) medical consultations; (vi) nursing
consultations; (vii) overall expenditures. For statistical
procedures, overall expenditures in T2DM treatment
were ranked and stratified into tertiles and the highest
tertile of expenditure was adopted as “high healthcare
expenditure indicator”.
Diabetic Neuropathy
Diabetic neuropathy was evaluated using 10 g of
Semmes-Weinstein monofilament, according to the Bra-
zilian Consensus on Chronic Complications from the
Brazilian Society of Diabetes [16]. Touch and pressure
perception was tested in the plantar region, in the
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st.,
3
rd. and 5
th. metatarsal and 1
st., 3
rd.a n d5
th. toes). Each
area had its sensitivity tested at least three times, in
order to determine the outcome (outcome presence was
determined as failing to perceive the monofilament at
least one time). Lack of monofilament perception into
two or more regions identified the presence of diabetic
neuropathy.
Structured interview and anthropometry
On the same day as the diabetic neuropathy assessment,
a structured face-to-face interview and anthropometric
measures were carried out in a quiet room at the BHU
by a trained researcher. Initially, some data were
obtained through interviews and confirmed in the medi-
cal records: (i) socio-demographic variables (sex, chron-
ological age [structured as categorical variable: <50
years-old and ≥50 years-old] and skin color [white,
black, yellow and other]; (ii) smoking habits (diabetics
were categorized as (current smokers [independently of
number of cigarettes per day]; former smokers; never
smoked); (iii) last fasting glucose test (<99 mg/dL; 100-
125.9 mg/dL; ≥126 mg/dL); (iv) exogenous insulin use
(either “yes” or “no”); (v) physical activity (described
below). In sequence, the following anthropometric mea-
surements were done: body mass index (BMI) and
waist-to-hip ratio (WHR) were calculated using mea-
surements of weight, height, waist and hip circumfer-
ences done according to Lohman et al. [17]. BMI was
obtained dividing weight by squared height (kg/m
2)a n d
WHR was calculated dividing waist circumference by
hip circumference. Presence of obesity was diagnosed
when BMI was ≥30 kg/m
2 and occurrence of high WHR
was diagnosed by gender-adjusted cutoffs (male = 0.95
m and female = 0.80 m) [18].
Physical Activity Level
Physical activity level was estimated using the question-
naire developed by Baecke et al. [19], which takes into
count three physical activity domains: occupational,
sports and leisure and mobility. The questionnaire con-
sists of 16 questions and is scored on a 5-point Likert
scale, ranging from never to sometimes/very often.
Additional questions report the type of sport, number of
hours per week and the number of months per year in
which this sport was performed [10,19]. The scoring of
the questionnaire includes specific scoring criteria for
each of the three domains and the sum of the values in
all domains represents the total physical activity [10,19].
In order to categorize the physical activity levels regis-
tered, the formula proposed by Baecke et al. [19] was
used. The sample was divided into quartiles according
to total physical activity score provided by the instru-
ment: 1
st. Quartile ([mean score = 4.73 and 95%CI =
4.51 - 4.94] Sedentary, n = 31), 2
nd.a n d3
rd. Quartile
([mean score = 6.21 and 95%CI = 6.06 - 6.36] Moder-
ately Active, n = 58); and 4
th. Quartile ([mean score =
8.94 and 95%CI = 8.29 - 9.58] Active, n = 32).
Statistical procedures
Numerical variables were presented as mean and stan-
dard-deviation (SD). Student t test compared mean
values between men and women. Pearson correlation
analyzed the relationship between physical activity and
healthcare expenditures. Categorical data were expressed
as rates. Chi-square tests were applied to detect the
existence of significant associations among categorical
variables (Yates’ correction was used in 2 × 2 contin-
gence tables). A multivariate model was structured
using binary logistic regression (expressed as odds ratios
[OR] and 95% confidence intervals [95%CI]), inserting
potential confounding variables significant in univariate
chi-square (all categorized) to analyze the association
between physical activity and healthcare expenditures.
All statistical procedures were performed in the Statisti-
cal Package for the Social Sciences (SPSS), version 13.0,
and the significance (p) was set at 5%.
Results
T h em e a na g ew a s6 0 . 1±8 . 9y e a r s ,r a n g i n gf r o m3 2 . 7
to 75.0 years. The mean BMI and fasting glucose were
30.6 ± 6.5 kg/m
2 and 164.9 ± 72.1 mg/dl, respectively.
The number of medical consultations per year was 1.83,
ranging from 0 to a maximum of 6. Table 1 shows the
general characteristics of the sample grouped, according
to gender. Mean values of public health expenditures
and physical activity score were similar in men and
women (p > 5%), but women presented higher expendi-
tures on medication for other diseases (p = 0.006). The
sample included mainly white individuals, presenting
poor glycemic control and high percentage of subjects
with increased adiposity. Women presented higher pre-
valence of overweight and obesity (p = 0.008) and ele-
vated WHR (p = 0.003). Physical activity level was not
associated with gender (p = 0.586).
In our sample, the total expenditures were approxi-
mately US$ 18,500 and medication for T2DM repre-
sented 58.4% of these overall expenditures (medication
for other diseases 4.7% and medication for T2DM treat-
ment 53.7%). Nursing consultations, medical consulta-
tions and laboratory tests represented 24.5%, 7.6% and
9.5% of the overall cost, respectively.
Diabetic individuals aged over 50 years presented
higher expenditures on medication for the treatment of
diseases other than T2DM (p = 0.041). Smoke habit was
not associated with any expenditure indicator (Table 2).
As could be expected, insulin use was associated with
increased expenditures in general medication (p =
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Additionally, insulin use was also associated with higher
expenditures in medical consultations (p = 0.005), nur-
sing consultations (p = 0.001) and overall public health-
care expenditures (p = 0.001).
WHR was positively associated with expenditures on
medication for diseases other than T2DM (p = 0.045). Dia-
betic neuropathy was not associated with increased expen-
ditures in healthcare (Table 2). There was an association
between physical inactivity and public expenditures in
healthcare for medication to treat diseases other than dia-
betes (p = 0.006) and medical consultations (p = 0.026).
Sedentary and moderately active diabetics presented simi-
lar results (p > 5% in all comparisons).
The logistic regression results (Table 3) show that physi-
cally active diabetic individuals were 81% less likely to be in
the highest tertile of expenditures due to treatment of other
diseases (p = 0.007) and 74% less likely to be in the highest
tertile of expenditures on medical consultations (p = 0.029)
when compared to sedentary diabetic individuals. Expendi-
tures on laboratory tests present e do n l yam a r g i n a l l ys i g n i f i -
cant association (decreased odds of 62%; p = 0.092).
Age (r = 0.20; p = 0.023), BMI (r = 0.33; p = 0.001)
and WHR (r = 0.20; p = 0.025) also were related to
medication for other diseases. Physical activity score was
negatively related to expenditures on medical consulta-
tions (r = - 0.23; p = 0.011) and medication for other
diseases (r = - 0.23; p = 0.010).
Table 1 Socio-demographic, anthropometric and health characteristics in a sample of type 2 diabetic individuals,
according to gender (Brazil, 2009)
Variables Overall
(n = 121)
Male
(n = 49)
Female
(n = 72)
P
Mean ± SD Mean ± SD Mean ± SD
Age in years 60.1 ± 8.9 59.8 ± 9.9 60.2 ± 8.3 0.802
BMI (kg/m
2) 30.6 ± 6.5 28.2 ± 4.9 32.3 ± 7.1 0.001
Physical activity score 6.5 ± 1.8 6.6 ± 1.8 6.4 ± 1.8 0.663
Medical consultations per year 1.83 ± 1.4 1.86 ± 1.5 1.82 ± 1.3 0.884
Laboratory tests (US$) 14.5 ± 1.3 14.2 ± 2.1 14.7 ± 1.7 0.872
Medication (US$) 89.1 ± 10.8 98.8 ± 17.4 82.1 ± 13.8 0.461
T2DM medication (US$) 81.9 ± 10.9 93.7 ± 17.4 73.9 ± 13.9 0.376
Other medication (US$) 7.1 ± 0.6 5.1 ± 0.7 8.5 ± 0.9 0.006
Medical consultation (US$) 7.8 ± 0.4 8.1 ± 0.8 7.9 ± 0.5 0.859
Nursing consultation (US$) 37.4 ± 1.2 39.5 ± 1.3 35.9 ± 1.9 0.128
Overall expenditures (US$) 148.9 ± 11.7 160.5 ± 17.7 140.5 ± 14.1 0.481
Skin color (%) 0.361
White 71.9 73.5 70.8
Black 18.2 10.2 23.6
Yellow 6.6 10.2 4.2
Other 3.3 6.1 1.4
Fasting glucose (%) 0.238
<99 mg/dl 9.1 10.2 8.3
100-125 mg/dl 22.3 28.6 18.1
≥126 mg/dl 68.6 61.2 73.6
WHR (%) 0.003
Normal 13.2 24.5 5.5
High 86.8 75.5 94.4
BMI (%) 0.008
<25 kg/m
2 18.2 24.5 13.9
25-29.9 kg/m
2 35.5 44.9 29.2
≥30 kg/m
2 46.3 30.6 56.9
Smoking habit (%) 11.6 16.3 8.3 0.289
Exogenous insulin use (%) 36.4 42.9 31.9 0.302
Diabetic neuropathy (%) 26.4 32.7 22.2 0.286
Physically active (%) 26.4% 24.5 27.8 0.586
SD = standard-deviation; BMI = body mass index; WHR = waist-to-hip ratio; T2DM = type 2 diabetes mellitus
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Older diabetic individuals presented higher expenditures
on medication for the treatment of diseases other than
T2DM. Similarly, Plotnikoff et al. [20] identified that age
was positively related to healthcare utilization in Cana-
dian persons with both types of diabetes. In fact, ageing
is frequently pointed out as an independent risk factor
for development of several chronic diseases, including
T2DM [1,3,8,21]. Additionally, the period of disease
onset during the lifespan may be a determinant of the
magnitude in healthcare expenditures, due to the co-
morbidities associated to prolonged diabetes [22,23].
Regular use of exogenous insulin increased healthcare
expenditures significantly with T2DM treatment among
all patients, an expected result, since exogenous insulin is
one of the most expensive medications financed by the
Brazilian public health system. Higher expenditures on
medical consultations and nursing consultations among
exogenous insulin users, however, were relatively unex-
pected results. Nevertheless, the major part of the differ-
ence identified was related to consultations for medication
dispensing, that is, insulin-dependent patients would
r e q u i r em o r ef r e q u e n tc o n s u ltations than non-insulin-
dependent patients, given that insulin demand special cau-
tion in storage and transportation. Furthermore, exogen-
ous insulin is a pharmacological tool used by diabetic
subjects with poor glycemic control and, in turn, with
more complications of the disease. Khattab et al. [23]
Table 2 Higher public healthcare expenditures prevalence in a sample of type 2 diabetic subjects with different socio-
demographic and health characteristics, according to expenditure categories (Brazil, 2009)
Independent variables Expenditure category: higher tertile (n [%])
i ii iii iv v vi vii
Laboratory
tests
Medication T2DM
medication
Other
medication
Medical
consultation
Nursing
consultation
Overall
expenditure
Age <50 years-old 11 (37.9) 12 (41.2) 12 (41.4) 5 (17.2) 13 (44.8) 9 (31) 12 (41.4)
≥50 years-old 29 (31.5) 28 (30.4) 28 (30.4) 37 (40.2)* 27 (29.3) 40 (43.5) 28 (30.4)
Smoking habit No 35 (32.7) 36 (33.6) 36 (33.6) 40 (37.4) 34 (31.8) 42 (39,3) 36 (33.6)
Yes 5 (35.7) 4 (28.6) 4 (28.4) 2 (14.3) 6 (42.9) 7 (50) 4 (28.6)
Exogenous
insulin use
No 24 (31.2) 0 (0) 0 (0) 27 (35.1) 18 (23.4) 20 (26) 0 (0)
Yes 16 (36.4) 40 (90.9)** 40 (90.9)** 15 (34.1) 22 (50)** 29 (65.9)** 40 (90.9)**
BMI <29.9 kg/m
2 19 (29.2) 24 (36.9) 24 (36.9) 22 (33.8) 21 (32.3) 30 (46.2) 24 (36.9)
≥30 kg/m
2 21 (37.5) 16 (28.6) 16 (28.6) 20 (35.7) 19 (33.9) 19 (33.9) 16 (28.6)
WHR Normal 5 (31.3) 5 (31.3) 5 (31.3) 2 (12.5) 6 (37.5) 5 (31.3) 5 (31.3)
High 35 (33.3) 35 (33.3) 35 (33.3) 40 (38.1)* 34 (32.4) 44 (41.9) 35 (33.3)
Diabetic
Neuropathy
No 30 (33.7) 29 (32.6) 29 (32.6) 33 (37.1) 32 (36) 37 (41.6) 29 (32.6)
Yes 10 (31.3) 11 (34.4) 11 (34.4) 9 (28.1) 8 (25) 12 (37.5) 11 (34.4)
Sedentary 13 (41.9) 12 (38.7) 12 (38.7) 16 (51.6) 14 (45.2) 13 (41.9) 12 (38.7)
Physical activity M. Active 20 (34.5) 18 (31) 18 (31) 20 (34.5) 20 (34.5) 24 (41.4) 18 (31)
Active 7 (21.9) 10 (31.3) 10 (31.3) 6 (18.8)
§ 6 (18.8)
§ 12 (37.5) 10 (31.3)
§ = p < 0.05 compared to Sedentary; * = chi-square test with p < 0.05; ** = chi-square test with p < 0.01; M. Active = moderately active; T2DM = type 2 diabetes
mellitus; BMI = body mass index; WHR = waist-to-hip ratio.
Table 3 Logistic regression results to determinate association with public healthcare expenditures in type 2 diabetics
(Brazil, 2009)
Independent
variable
Expenditure category (higher tertile)
i ii iii iv v vi vii
Laboratory
tests
Medication T2DM
medication
Other
medication
Medical
consultation
Nursing
consultation
Overall
expenditure
ORadj1 (95%CI) ORadj2 (95%CI) ORadj1 (95%CI)* ORadj3 (95%CI) ORadj2 (95%CI) ORadj2 (95%CI) ORadj2 (95%CI)
PAL Sedentary 1.00 1.00 1.00 1.00 1.00 1.00 1.00
M. Active 0.72 (0.29-1.78) 0.70 (0.28-1.77) 0.71 (0.28-1.77) 0.40 (0.15-1.05) 0.33 (0.25-1.61) 1.02 (0.39-2.67) 0.70 (0.28-1.77)
Active 0.38 (0.12-1.16) 0.69 (0.25-2.03) 0.72 (0.25-2.03) 0.19 (0.06-0.64) 0.26 (0.08-0.87) 0.87 (0.29-2.62) 0.69 (0.25-2.03)
* = insulin use was significantly associated with T2DM in chi-square test, however, it was not inserted in logistic regression as adjust; OR = odds ratios; ORadj1 =
odds ratio adjusted by gender and skin color; ORadj2 = odds ratio adjusted by gender, skin color and insulin use; ORadj3 = odds ratio adjusted by gender, skin
color, age and waist-to-hip ratio; 95%CI = 95% confidence interval; T2DM = type 2 diabetes mellitus; PAL = physical activity level; M. Active = moderately active
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oral antidiabetic agents have lower glycemic control than
diabetics with only oral antidiabetic agents. Our hypothesis
is strengthened, because 69% of the diabetics presented
low effectiveness in glycemic control. Thus, the presented
results indicated that there is high proportion of diabetic
patients with poor glycemic control and this event strongly
increases the healthcare costs.
In obese persons, evidence indicates that adipose tissue
(mainly visceral) releases a variety of adipokines asso-
ciated with insulin resistance, dyslipidemia and arterial
hypertension [24], suggesting that obesity has central role
in the genesis of T2DM. Worldwide being overweight
and obese have been associated with increased healthcare
expenditures among adult populations [6,25]. The results
presented in this paper reinforce evidence previously
published, since higher BMI and WHR were significantly
related to higher expenditures on medication for chronic
diseases other than diabetes. Moreover, our findings call
attention to the high occurrence of general and central
obesity among individuals with T2DM.
Diabetic neuropathy was not related to increased
costs, disagreeing with previous data, in which the pre-
sence of diabetic neuropathy significantly increased
healthcare costs [26]. Even with the presence of foot
u l c e r a t i o ni ns o m ep a t i e n t s( n=8 ) ,n o n eo ft h e s eh a d
either previous diagnosis of diabetic neuropathy or
received medication for the treatment of neuropathy
(e.g. pain medication). This lack of preventive care
related to diabetic neuropathy would justify the absence
of differences and constitutes a concern due to the
increased risk of ulceration.
Diabetic individuals engaged in physical exercise for at
least 30 minutes per day present better glycemic control
and lower medication use than sedentary ones [12,23]
and this relationship appears stronger in T2DM than
type 1 [20]. The present study observed the same pat-
terns in the association between habitual physical activ-
ity and expenditures on medication for treatment of
diseases other than diabetes (e.g. antihypertensive and
hypolipidemic agents). There is a well-documented ben-
eficial effect of physical activity in metabolic and cardio-
vascular outcomes. Regular participation in physical
activities acts on different biologic pathways increasing
nitric oxide release, clearing of fat free acids and
decreasing in oxidative stress, physiological processes
associated with a decrease in the risk for arterial hyper-
tension, dyslipidemia and T2DM [27-29]. Among type 2
diabetic individuals, higher physical fitness is inversely
related to blood pressure, body fatness, uric acid and
total cholesterol [30]. Therefore it is possible that such
multiple beneficial effects from habitual physical activ-
ities may be the reason for the decrease identified in
public healthcare expenditures due to medication and
laboratory tests.
In fact, physically active diabetic individuals are less
susceptible to disease complications, resulting in lower
expenditures on general medical consultations. On the
other hand, the lower number of general medical con-
sultations could also be associated to a better self-
perception of health, since physical activity has also
been significantly associated with a better quality of self-
perception of health [31].
It is noteworthy that our study only calculated expen-
ditures related to preventive medicine, while expendi-
tures generated by complications of the T2DM were not
(hospitalization and emergency room). Our results sug-
gests that the impact of large preventive actions target-
ing diabetic patients attended by public health care
system can have relevant contribution in the reducing
both the occurrence and the costs of these secondary
outcomes. Thus, it will also be necessary that health
professionals orientate diabetic patients in leading a
healthy lifestyle by means of physical activity and other
healthy behaviors.
Limitations must be recognized. First, the cross-sectional
design does not offer support for causality statements
in the relationship between healthcare expenditures and
physical activity level. Second, metabolic equivalents,
steps, counts and time of activity are commonly used to
describe physical activity and, therefore, there are guide-
lines based on these variables. On the other hand, the
Baecke questionnaire provides a specific score without
previously proposed cutoff, limiting the generalization of
the results. Third, the burden of both hospitalizations and
other diabetic complications/co-morbidities in overall
expenditures had not been calculated and, therefore,
should also be identified as both a limitation and a possi-
ble focus for future studies analyzing the relationship
between physical activity and healthcare expenditures
among diabetic patients.
Conclusions
In summary, the results indicate that type 2 diabetic
patients attending public healthcare units with higher
engagement in physical activity presented consistently
lower healthcare expenditures for the public healthcare
system. The decrease observed in expenditures to treat
the diabetic patients was mainly due to the reduction in
medicines used to treat diseases other than T2DM and
medical consultations, which represent approximately
12% of the overall cost related to preventive services.
Therefore, habitual physical activity promotion could be
an important strategy for healthcare systems to decrease
costs associated with the treatment of diabetes and its
co-morbidities.
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